InvestSMART

Ceryvyn Therapeutics Limited (ASX:OPT)

ALERT: Price-sensitive ASX Announcement for OPT
Current share price for OPT : $0.013 -0.587 (-97.83%)+
Release
3 Jun 2026 8:48AM
Price at Release
$0.600
Full Release
download
Summary
Opthea Limited announced the reinstatement of its trading on the ASX following the completion of a strategic review. The trading suspension is lifted as Opthea released an announcement regarding the review's completion, allowing the company to resume its normal trading activities.
Key Points
  • Reinstatement to quotation for Opthea Limited.
  • Trading suspension lifted after strategic review announcement.
  • Opthea resumes normal trading on ASX.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.